Ocular Immunology and Inflammation · 2005 · 13 citations · 23 references
MedicineImmunologyPathologyImmunopathologyOcular ImmunologyOcular PathologyAutoimmune Eye DiseaseAutoimmune Ocular DiseaseConjunctival ImmunologyEosinophilic DisordersImmunopathology Of The EyeOcular InflammationConjunctival Eosinophilic InflammationDisease Progression PredictionEosinophil-mediated InflammationEosinophil-mediated ResponsesEosinophilic InfiltratesEosinophilic Ocular InflammationSystemic Disease CorrelationTissue Eosinophilia
PURPOSE: To investigate the relation between eosinophil activation in tissue from patients with an active, limited form of Wegener's granulomatosis (WG) affecting the eye and subsequent systemic disease activity. METHODS: Analysis of ocular specimens obtained from 10 patients was performed. Sections were probed with antibodies to assess the presence of major basic protein (MBP) and eosinophil cationic protein (ECP). RESULTS: Four of the 10 specimens demonstrated the presence of MBP and ECP. WG progressed to the complete form in two of these patients, who received no or inadequate treatment. The other two, treated with cyclophosphamide for one year, did not progress to the complete form of WG during observation after therapy. CONCLUSIONS: Activated eosinophils in sclera or conjunctiva of patients with ocular limited WG may predict progression to complete WG.
23
Wegener Granulomatosis: An Analysis of 158 Patients
Gary S. Hoffman, Gail S. Kerr, Randi Y. Leavitt et al. · Annals of Internal Medicine · 1992 · 2.9K citations
John L. Fahey, Edward P. Leonard, Jacob Churg et al. · The American Journal of Medicine · 1954 · 674 citations
Wegener's granulomatosis: pathology and review of the literature.
Gabriel C. Godman, Jacob Churg · PubMed · 1954 · 597 citations
Ocular Complications of Wegener's Granulomatosis
Cynthia L. Bullen, Thomas J. Liesegang, Thomas J. McDonald et al. · Ophthalmology · 1983 · 388 citations